Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.32
+0.08 (1.53%)
At close: Apr 2, 2026, 4:00 PM EDT
5.33
+0.01 (0.23%)
After-hours: Apr 2, 2026, 4:42 PM EDT

Sagimet Biosciences Stock Forecast

Stock Price Forecast

The 8 analysts that cover Sagimet Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $26.38, which forecasts a 395.86% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $35.

Price Target: $26.38 (+395.86%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$8.00$26.38$28$35
Change+50.38%+395.86%+426.32%+557.89%

Analyst Ratings

The average analyst rating for Sagimet Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy555665
Buy332222
Hold001111
Sell000000
Strong Sell000000
Total888998

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$29
Strong BuyReiterates$29+445.11%Mar 11, 2026
Guggenheim
Guggenheim
Strong Buy
Initiates
$27
Strong BuyInitiates$27+407.52%Feb 3, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$29
Strong BuyReiterates$29+445.11%Feb 3, 2026
Barclays
Barclays
Hold
Initiates
$8
HoldInitiates$8+50.38%Jan 28, 2026
Citizens
Citizens
Buy
Maintains
$33$35
BuyMaintains$33$35+557.89%Nov 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
3.96M
EPS This Year
-2.00
from -1.58
EPS Next Year
-2.29
from -2.00
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
--2.00M---3.96M
Revenue Growth
-------
EPS
-199.40-165.20-2.66-1.45-1.58-2.00-2.29
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1311
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/a38.7M
Avgn/a4.0M
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-1.68-1.29
Avg-2.00-2.29
Low-2.47-3.40

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.